Sponsor:
Merck Sharp & Dohme LLC
Code:
NCT06305767
Conditions
Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
V940
Placebo
Enfortumab Vedotin
Surgery (RC plus PLND)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations